Department of Microbiology, University of Washington School of Medicine, Seattle, Washington, USA.
AIDS. 2012 Jan 14;26(2):193-205. doi: 10.1097/QAD.0b013e32834db418.
The potential for changing HIV-1 virulence has significant implications for the AIDS epidemic, including changing HIV transmission rates, rapidity of disease progression, and timing of ART. Published data to date have provided conflicting results.
We conducted a meta-analysis of changes in baseline CD4(+) T-cell counts and set point plasma viral RNA load over time in order to establish whether summary trends are consistent with changing HIV-1 virulence.
We searched PubMed for studies of trends in HIV-1 prognostic markers of disease progression and supplemented findings with publications referenced in epidemiological or virulence studies. We identified 12 studies of trends in baseline CD4(+) T-cell counts (21, 052 total individuals), and eight studies of trends in set point viral loads (10 ,785 total individuals), spanning the years 1984-2010. Using random-effects meta-analysis, we estimated summary effect sizes for trends in HIV-1 plasma viral loads and CD4(+) T-cell counts.
Baseline CD4(+) T-cell counts showed a summary trend of decreasing cell counts [effect = -4.93 cells/μl per year, 95% confidence interval (CI) -6.53 to -3.3]. Set point viral loads showed a summary trend of increasing plasma viral RNA loads (effect = 0.013 log(10) copies/ml per year, 95% CI -0.001 to 0.03). The trend rates decelerated in recent years for both prognostic markers.
Our results are consistent with increased virulence of HIV-1 over the course of the epidemic. Extrapolating over the 30 years since the first description of AIDS, this represents a CD4(+) T cells loss of approximately 148 cells/μl and a gain of 0.39 log(10) copies/ml of viral RNA measured during early infection. These effect sizes would predict increasing rates of disease progression, and need for ART as well as increasing transmission risk.
HIV-1 毒力变化的可能性对艾滋病流行具有重大意义,包括改变 HIV 传播率、疾病进展速度和开始 ART 的时间。迄今为止已发表的数据提供了相互矛盾的结果。
我们对 HIV-1 疾病进展预后标志物的基线 CD4+T 细胞计数和时间上的设定点血浆病毒 RNA 载量变化进行了荟萃分析,以便确定总结趋势是否与 HIV-1 毒力变化一致。
我们在 PubMed 中搜索了 HIV-1 疾病进展预后标志物变化趋势的研究,并补充了流行病学或毒力研究中参考文献的出版物。我们确定了 12 项关于基线 CD4+T 细胞计数变化趋势的研究(21052 人),以及 8 项关于设定点病毒载量变化趋势的研究(10785 人),这些研究跨越了 1984 年至 2010 年。使用随机效应荟萃分析,我们估计了 HIV-1 血浆病毒载量和 CD4+T 细胞计数变化趋势的汇总效应大小。
基线 CD4+T 细胞计数呈现出细胞计数下降的总结趋势[效应=-4.93 个/μl/年,95%置信区间(CI)-6.53 至-3.3]。设定点病毒载量呈现出血浆病毒 RNA 载量增加的总结趋势(效应=0.013 log(10)拷贝/ml/年,95%置信区间(CI)0.001 至 0.03)。近年来,这两种预后标志物的趋势速度都有所减缓。
我们的结果与 HIV-1 在流行过程中毒力增强一致。推断自艾滋病首次描述以来的 30 年中,这代表了大约 148 个细胞/μl 的 CD4+T 细胞损失和 0.39 log(10)个拷贝/ml 的病毒 RNA 增加,这些都是在早期感染期间测量的。这些效应大小将预测疾病进展速度的增加,以及对 ART 的需求以及增加的传播风险。